|
WO2020261283A1
|
|
A composition of cannabidiol for use in the treatment and prevention of bronchiolitis obliterans
|
|
WO2020202103A1
|
|
Mitochondrial transplantation and use thereof in ocular diseases
|
|
WO2020178760A1
|
|
Devices and methods for capsule shielding in cataract surgery
|
|
WO2020161651A1
|
|
Early detection of multiple resistances to anti-bacterial treatment
|
|
EP3814375A1
|
|
Antibodies for the treatment of synucleinopathies and neuroinflammation
|
|
EP3814376A1
|
|
Transthyretin antibodies and uses thereof
|
|
WO2019224754A1
|
|
Toll-like receptor 4 (tlr4) inhibitors and use thereof
|
|
WO2019220307A1
|
|
Apparatus for harvesting energy from relative motion of body parts, particularly an eyeball and an eyelid
|
|
EP3774924A1
|
|
Anti-telomerase reverse transcriptase antibodies and use thereof
|
|
WO2019186414A1
|
|
Cervical dilator
|
|
WO2019166961A1
|
|
Self-supporting surgical guide
|
|
US2019167711A1
|
|
Methods for diagnosis and treatment of acute lymphoblastic leukemia
|
|
IL263905D0
|
|
Combination therapy of cancer
|
|
CN111417392A
|
|
Cannabidiol and chitosan compositions and methods of use thereof
|
|
WO2019077482A1
|
|
A system and method for use in disease treatment management
|
|
WO2019064136A1
|
|
Eeg microstates analysis
|
|
WO2019043613A1
|
|
Peritoneal sodium-glucose transporter (sglt) inhibitors for improvement of peritoneal dialysis
|
|
WO2019025901A1
|
|
Systems and methods of predicting onset of sepsis
|
|
GB201811794D0
|
|
Tissue clamping device
|
|
GB201811220D0
|
|
Removable cover arrangement for medical devices
|
